References
Yamada M, Ishikawa Y, Imadome KI. Hypersensitivity to mosquito bites: a versatile Epstein-Barr virus disease with allergy, inflammation, and malignancy. Allergol Int 2021; 70: 430–8.
Chiu TM, Lin YM, Wang SC, Tsai YG. Hypersensitivity to mosquito bites as the primary clinical manifestation of an Epstein-Barr virus infection. J Microbiol Immunol Infect 2016; 49: 613–6.
Wada T, Yokoyama T, Nakagawa H, et al. Flow cytometric analysis of skin blister fluid induced by mosquito bites in a patient with chronic active Epstein-Barr virus infection. Int J Hematol 2009; 90: 611–5.
Vander Does A, Labib A, Yosipovitch G. Update on mosquito bite reaction: itch and hypersensitivity, pathophysiology, prevention, and treatment. Front Immunol 2022; 13: 1024559.
Tokura Y, Ishihara S, Tagawa S, Seo N, Ohshima K, Takigawa M. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol 2001; 45: 569–78.
Meucci E, Radice A, Fassio F, Iorno MLC, Macchia D. Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy. Clin Case Rep 2021; 9: e04935
Funding
Financial support none.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest none.
About this article
Cite this article
Nishiyori, R., Sakai, T., Nishida, H. et al. An unusual case of immediate and delayed hypersensitivity to wasp stings. Eur J Dermatol 33, 701–703 (2023). https://doi.org/10.1684/ejd.2023.4630
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2023.4630